Thiazide-like Diuretic side effects compared: 3 drugs, 40,523 FDA adverse event reports
Members
| Drug | FAERS reports | Serious | Death outcome | Boxed warning | Top labeled signals | Unlabeled (unassessed) |
|---|---|---|---|---|---|---|
| Indapamide | 17,816 | 93% | 1,137 | – | Hyponatraemia; Central nervous system lupus | Butterfly rash; Lupus nephritis |
| Chlorthalidone | 11,542 | 63% | 690 | – | Chronic kidney disease; Hyponatraemia; Blood potassium decreased | End stage renal disease; Cardiac murmur |
| Metolazone | 11,165 | 79% | 2,203 | – | Metabolic alkalosis | End stage renal disease; Fluid overload |
Class-wide signals (flagged in at least 2 of 3 members)
| Reaction | Members flagged | Median PRR | Reports (sum) | In label |
|---|---|---|---|---|
| Chronic kidney disease-mineral and bone disorder | 2/3 | 56.6 | 64 | 0/2 members' labels |
| Nephrogenic anaemia | 2/3 | 48.9 | 240 | 0/2 members' labels |
| Hyperparathyroidism secondary | 2/3 | 45.9 | 122 | 1/2 members' labels |
| Renal artery stenosis | 2/3 | 31.0 | 62 | 0/2 members' labels |
| Metabolic alkalosis | 2/3 | 27.8 | 47 | 2/2 members' labels |
| Rebound acid hypersecretion | 2/3 | 25.7 | 84 | 0/2 members' labels |
| End stage renal disease | 2/3 | 22.1 | 431 | 0/2 members' labels |
| Hyponatraemia | 2/3 | 19.0 | 1,616 | 2/2 members' labels |
Member-specific signals (flagged in exactly one drug)
No strong single-member signals (n ≥ 50) in this class.
Common questions
Which thiazide-like diuretic has the most FDA adverse event reports?
Indapamide has the most FAERS co-reports in this class (17,816), followed by Chlorthalidone (11,542). Report volume tracks how widely and how long a drug has been used, and how much attention it has had, far more than its risk.
Which side effects are shared across thiazide-like diuretic drugs?
Reaction terms flagged in at least half of the 3 members include chronic kidney disease-mineral and bone disorder, nephrogenic anaemia, hyperparathyroidism secondary, renal artery stenosis, metabolic alkalosis. A term shared across a class usually reflects the shared mechanism (or the shared patient population) rather than one product.
Does a FAERS signal mean the drug causes the reaction?
No. These are disproportionality signals from voluntary reports with no denominator. Each is screened against the FDA label (known vs unlabeled) on the drug pages; causality needs temporality, dose-response, plausibility and trial or cohort evidence.
Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, seriousness and death counts from openFDA count queries. Generated 2026-10-08. Not medical advice.